The Bottom Line First
VNO science doesn’t mean pheromones don’t work.
It means that if they work, the mechanism is different from what we see in rodents. Understanding this helps set realistic expectations and optimize usage.
Common Misconceptions
Myth: “No VNO = No Pheromones”
Reality: The VNO is just one potential detection pathway. Humans have:
- Main olfactory epithelium with ~400 functional receptor genes
- Cranial Nerve Zero projecting to reproductive brain regions
- Skin and mucosal absorption routes
VNO non-functionality doesn’t close all doors — it just means we need to look through different ones.
Myth: “Human pheromone products are all scams”
Reality: Multiple peer-reviewed studies show humans respond to chemical signals:
- Menstrual synchronization effects (debated but observed)
- Mood changes from androstadienone exposure
- Cortisol modulation by male compounds
- Behavioral changes in controlled studies
The mechanism is unclear, but effects are documented.
Myth: “Products should target the VNO”
Reality: Since the VNO is non-functional, targeting it is pointless. Instead:
- Focus on compounds the main olfactory system can detect
- Consider proximity for CN0 activation
- Don’t believe marketing that claims “VNO activation”
What the Science Actually Tells Us
1. Detection Pathway Matters
If you want to maximize effect, understand how compounds might be detected:
| Pathway | Characteristics | Implications |
|---|---|---|
| Main Olfactory | Volatile compounds, conscious smell | Cover scents may interfere |
| Cranial Nerve Zero | Proximity, possibly non-volatile | Close contact more important |
| Bloodstream | Skin absorption | Application site matters |
2. Rodent Research ≠ Human Effects
Many pheromone claims are based on rodent studies using VNO-mediated responses. These findings may not translate to humans because:
- Humans lack functional VNO receptors
- Detection mechanism differs
- Behavioral responses differ
- Dosing/concentration may not scale
Be skeptical of claims citing mouse studies.
3. Individual Variation is Expected
Some people:
- Have residual VNO structures, others don’t
- Have different OR7D4 variants (androstenone perception)
- May have varying CN0 sensitivity
- Process chemical signals differently
This explains why the same product works differently for different users.
Practical Recommendations
Application Strategy
Based on non-VNO pathways:
For Volatile Compounds:
- Apply to skin (body heat increases volatility)
- Upper body placement (neck, chest, wrists)
- Don’t over-apply (can overwhelm olfactory system)
For Non-Volatile/Heavier Compounds:
- Proximity matters more
- Close conversation distance
- Physical contact increases exposure
Realistic Expectations
Based on the science:
What to Expect:
- Subtle shifts in perception/treatment
- Self-effects (your own response to compounds)
- Possible mood/confidence changes
- Enhanced, not replaced, social dynamics
What NOT to Expect:
- Instant, dramatic attraction
- “Mind control” effects
- Universal responses from everyone
- Effects from across a room
Product Selection
Consider:
- Compound type — Volatile vs. non-volatile
- Concentration — More isn’t always better
- Your response — Self-effects matter
- Application context — Social setting, proximity expected
The Hexadecanal Example
Recent research on hexadecanal (HEX) illustrates how complex this is:
- Compound found in human saliva, skin, feces
- Released by babies
- Effect on men: Decreased aggression
- Effect on women: Increased aggression
The researchers theorize this makes:
- Mothers more protective of infants
- Fathers less likely to harm offspring
This shows:
- Humans DO respond to chemical signals
- Responses can be sex-specific
- Context matters (baby care vs. general social)
- Effects are measurable but subtle
What This Means for the Community
Validation
The science validates that:
- Humans produce chemical signals
- These signals can affect others’ physiology and behavior
- Commercial pheromone products contain real compounds
Calibration
But it also suggests:
- Effects are likely subtle, not dramatic
- Individual variation is normal
- VNO-based marketing claims are unfounded
- Mechanism of action remains unclear
Future Direction
The community should:
- Focus on reproducible effects
- Document individual variation
- Consider alternative detection pathways
- Be skeptical of exaggerated claims
Key Takeaways
- VNO non-functionality doesn’t disprove pheromone effects
- Detection likely occurs through MOE, CN0, or other pathways
- Rodent research may not apply to humans
- Proximity and volatility affect detection
- Individual variation is expected and normal
- Self-effects are scientifically plausible
- Realistic expectations lead to better outcomes
The Pragmatic View
The practical pheromone user should:
- Use products that provide noticeable self-effects
- Apply appropriately for expected social distance
- Document personal observations
- Ignore VNO-based marketing claims
- Accept that mechanism ≠ effect
Whether or not we fully understand how pheromones work, what matters is whether they produce useful effects for you. The VNO science simply tells us to look for the mechanism elsewhere.
References
-
Wysocki CJ, Preti G. “Facts, fallacies, fears, and frustrations with human pheromones.” Anat Rec A. 2004;281(1):1201-11.
-
Trotier D. “Vomeronasal organ and human pheromones.” Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(4):184-90.
-
Gelstein S, et al. “Human tears contain a chemosignal.” Science. 2011;331(6014):226-30.
-
Mishor E, et al. “Sniffing the human body volatile hexadecanal blocks aggression in men but triggers aggression in women.” Sci Adv. 2021;7(47):eabg1530.